跳至主要内容
临床试验/IRCT2016111322869N2
IRCT2016111322869N2已完成2 期

Evaluation of effect of silymarin and vitamin E on liver enzyme of nonalcoholic steatohepatitis patients: results of a randomized clinical trial

Vice Chancellor for research of Yasuj University of Medical Sciences0 个研究点目标入组 114 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Major inclusion criteria: Diagnosis of non-alcoholic steatohepatitis disease by sonography and elevated liver enzymes; negative history of autoimmune hepatitis, viral hepatitis, Wilson disease, hemochromatosis, a-1 antitrypsin deficiency, diabetes, hypothyroidism, cardio-pulmonary disease, kidney disease, psychiatric disease, pregnancy, alcohol consumption; also negative history for using lipid lowering drugs such as atorvastatin and gemfibrozil, estrogen, tamoxifen, corticosteroids, amiodarone, acetaminophen more than 2 grams per day, chemotherapy drugs in six months ago, anti-seizure medications such as sodium valproate, carbamazepine, phenytoin, anti-tuberculosis drugs such as isoniazid, rifampin, perazinamide.
  • Major exclusion criteria: Patient’s displeasure to continue participation in the study; The incidence of drug-related complications.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Yasuj University of Medical Sciences

相似试验

Evaluation of effect of Livergol and vitamin E on... | 临床试验